Trails Edge Capital Partners, LP / SNDX
Trails Edge Capital Partners, LP’s Syndax Pharmaceuticals Inc Position
Does Trails Edge Capital Partners, LP own Syndax Pharmaceuticals Inc (SNDX)? Yes — 701.8K shares worth $16M (+3.76% of its 13F portfolio) as of Q1 2026.
Position Value
$16M
Q1 2026
Shares
701.8K
% of Portfolio
+3.76%
Quarters Held
1
currently held
Position History SNDX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 701.8K | $16M | +3.76% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Trails Edge Capital Partners, LP’s full portfolio or all institutional holders of SNDX.